J&J | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
AbbVie USD 610M 19M 2024-12
Abbott USD 49M 4M 2025-03
Amgen USD 723M 24M 2025-03
AstraZeneca 429M 28M 2024-12
Baxter International USD 100M 1000K 2024-12
Bayer 584M 119M 2025-03
Becton, Dickinson and Co. USD 151M 4M 2025-03
Biogen USD 60M 200K 2024-12
Boston Scientific USD 82M 2M 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
CONMED USD 8.29M 571K 2025-03
Cooper Companies USD 24.2M 1.8M 2025-04
Dexcom USD 4.7M 200K 2025-03
Edwards Lifesciences 15.5M 1000K 2024-06
Eli Lilly USD 243.7M 19M 2025-03
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Globus Medical 13K 828K 2025-03
Hologic USD 29.1M 1.4M 2025-03
Indivior 9M 1000K 2024-09
Insulet USD 1.2M 2.8M 2025-03
Integra LifeSciences USD 18.81M 169K 2025-03
Intuitive Surgical 74.9M 18.8M 2024-12
J&J USD 128M 9M 2025-03
Medtronic USD 174M 5M 2025-04
Merck USD 313M 15M 2025-03
Merit Medical Systems USD 6.57M 1.42M 2025-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Stryker 42M 11M 2024-09
Tandem Diabetes Care USD 1.86M 2K 2025-03
Teva Pharmaceutical Industries USD 212M 12M 2025-03
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Zimmer Biomet Holdings USD 61.9M 7.6M 2024-12
Zoetis USD 54M 3M 2025-03



J&J Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.